Empathy in Action: Sunshine Calls for Life With Diabetes
NCT ID: NCT05173675
Last Updated: 2024-05-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
260 participants
INTERVENTIONAL
2022-02-12
2024-04-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The EMPATHy Toolkit: Helping Diabetes Patients Overcome Barriers to Medication Adherence
NCT02324036
Teaching Adolescents with Type 1 Diabetes Self-compassion
NCT05463874
Breaking Down Barriers to Diabetes Self-Care
NCT00142922
Impact of ACT-based Interventions on Diabetes-related Outcomes
NCT04028427
Self-compassion to Reduce Diabetes Distress in Persons With Type 1 Diabetes
NCT05070949
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Program arm
Usual Care+
Phase 1 (6 months, months 1-6), Program. Includes empathetic communications (phone \& letter), health-promoting incentives, educational materials.
Phase 2 (6 months, months 7-12) No Program. During this follow-up period they will receive monthly SMS texts with customized messages encouraging health promoting behaviors.
Empathy in Action for life with diabetes.
In Phase 1 (Months 1-6) participants receive ("Program"):
1. Empathetic communications: A dedicated partner (lightly-trained lay person) who communicates with them via phone with timing and frequency defined by the participant within certain parameters. Two letters mailed during the 6 months that compile anonymized learnings from all participants in the callers panel of 10-20 participants, written as a newsletter to share back with the participant.
2. Material Incentives: One choice of health tool (weight scale or pedometer) selected with the caller in week 1 and expected to be received in weeks 3-5. Two small recognition gifts (valued at US$25) chosen by the caller based on their understanding of the participants preferences, and sent at month 2.5 and 4.5.
3. Educational Materials: Printed DM management educational materials mailed right after enrollment and randomization, and expected to be received in weeks 1-2.
Control arm
Usual Care+
Phase 1 (6 months, months 1-6), No Program.
Phase 2 (6 months, months 7-12) Material components of program including health-promoting incentives and educational materials.
Control Phase 2 Materials Only
1. Material Incentives:
a. Choice of health tool (weight scale or pedometer) and 2 health promoting gifts chosen by the caller at the end of their 6 month measurement visit.
i. Health tool is mailed out within the 7th month ii. Health promoting gifts are mailed out in the 8th and 10th month
2. Educational Materials a. The same educational materials mailed to participants in the intervention arm "Program" will be mailed to control arm participants after they complete their 6 months visit
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Empathy in Action for life with diabetes.
In Phase 1 (Months 1-6) participants receive ("Program"):
1. Empathetic communications: A dedicated partner (lightly-trained lay person) who communicates with them via phone with timing and frequency defined by the participant within certain parameters. Two letters mailed during the 6 months that compile anonymized learnings from all participants in the callers panel of 10-20 participants, written as a newsletter to share back with the participant.
2. Material Incentives: One choice of health tool (weight scale or pedometer) selected with the caller in week 1 and expected to be received in weeks 3-5. Two small recognition gifts (valued at US$25) chosen by the caller based on their understanding of the participants preferences, and sent at month 2.5 and 4.5.
3. Educational Materials: Printed DM management educational materials mailed right after enrollment and randomization, and expected to be received in weeks 1-2.
Control Phase 2 Materials Only
1. Material Incentives:
a. Choice of health tool (weight scale or pedometer) and 2 health promoting gifts chosen by the caller at the end of their 6 month measurement visit.
i. Health tool is mailed out within the 7th month ii. Health promoting gifts are mailed out in the 8th and 10th month
2. Educational Materials a. The same educational materials mailed to participants in the intervention arm "Program" will be mailed to control arm participants after they complete their 6 months visit
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least one visit with Lone Star Circle of Care within the past 12 months (in person or telehealth)
* Willing to answer the PHQ-9 form in its entirety at baseline data collection (due to stratified randomization design).
Exclusion Criteria
* Refusal to answer the PHQ-9 form in its entirety at baseline data collection.
* Moderate to severe cognitive impairment
* Currently pregnant (if of female sex)
* Undergoing cancer treatment
* Having diagnosis of end-stage renal disease or serious mental illness
* Having moderate to severe cognitive impairment
* Receiving systemic treatment with prednisone or immunosuppressant therapy following an organ transplant
21 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lone Star Circle of Care
UNKNOWN
University of Texas at Austin
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maninder Kahlon
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maninder Kahlon, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Texas at Austin
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lone Star Circle of Care at Ben White Health Clinic
Austin, Texas, United States
Lone Star Circle of Care at El Buen Samaritano
Austin, Texas, United States
Lone Star Circle of Care at Collinfield
Austin, Texas, United States
Lone Star Circle of Care at Northwest Austin
Austin, Texas, United States
Lone Star Circle of Care at Bastrop
Bastrop, Texas, United States
Lone Star Circle of Care at Cedar Park
Cedar Park, Texas, United States
Lone Star Circle of Care at Lake Aire Medical Center
Georgetown, Texas, United States
Lone Star Circle of Care at Pflugerville
Pflugerville, Texas, United States
Lone Star Circle of Care at Texas A&M Health Science Center
Round Rock, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kahlon MK, Aksan NS, Aubrey R, Clark N, Cowley-Morillo M, DuBois C, Garcia C, Guerra J, Pereira D, Sither M, Tomlinson S, Valenzuela S, Valdez MR. Glycemic Control With Layperson-Delivered Telephone Calls vs Usual Care for Patients With Diabetes: A Randomized Clinical Trial. JAMA Netw Open. 2024 Dec 2;7(12):e2448809. doi: 10.1001/jamanetworkopen.2024.48809.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00001571
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.